Nocopi Technologies adds independent director Eric Sites to its board
Nocopi Technologies, Inc. reported that its Board of Directors appointed Eric Sites as a Class I Director on December 15, 2025, filling an existing vacancy.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nocopi Technologies, Inc. reported that its Board of Directors appointed Eric Sites as a Class I Director on December 15, 2025, filling an existing vacancy. He will serve until the Company’s 2028 annual meeting of shareholders and until a successor is elected and qualified, subject to earlier departure events.
Sites is a Vice President at Horizon Kinetics Holding Corp. and serves as a Portfolio Manager and Research Analyst. He has prior board experience at the Canadian Securities Exchange, Bermuda Stock Exchange, Consensus Mining and Seigniorage Company, and Renn Fund, and is currently a Director of IL&FS Securities Services Ltd of India. The Board determined that he is independent under New York Stock Exchange and Nasdaq rules. The Company states there are no appointment-related arrangements, no family relationships with its directors or officers, and no related-party transactions involving Sites requiring disclosure.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did Nocopi Technologies (NNUP) disclose?
How long will Eric Sites serve on the Nocopi Technologies (NNUP) board?
What is Eric Sites’ professional background relevant to Nocopi Technologies (NNUP)?
Is Eric Sites considered an independent director at Nocopi Technologies (NNUP)?
Were there any special arrangements leading to Eric Sites’ appointment at Nocopi Technologies (NNUP)?
AI-generated analysis. How Rhea-AI works. Not financial advice.